GTCR, Carlyle in Talks to Acquire Albany Molecular Research

6/6/17

Buyout firms GTCR LLC and Carlyle Group LP (CG.O) are in talks to team up and jointly acquire U.S. contract drug manufacturer and researcher Albany Molecular Research Inc (AMRI.O), people familiar with the matter said on Monday.

A deal would come amid a wave of dealmaking in the pharmaceutical contract manufacturing sector. Last month, medical instrumentation maker Thermo Fisher Scientific Inc (TMO.N) agreed to acquire contract drug manufacturer Patheon NV (PTHN.N) for around $7.2 billion.

Negotiations are ongoing, and there is no certainty that the talks will lead to Albany Molecular Research being taken private, the sources said.

READ FULL ARTICLE HERE

Recent Deals

Interested in advertising your deals? Contact Edwin Warfield.